InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-13.2%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by ENGELSEN STEINAR J, Director. Officer active across 3 companies, notably INSMED Inc. Aggregated, 4 disclosures have been recorded. Split: 2 buys · 0 sell. Total volume traded: €743k. Activity tracked since 1 November 2021. The latest transaction was disclosed on 1 November 2021 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations4 total
14,235 shares@ US$30.14100.0% of flowCommon StockSEC:0001140361-21-036421
Ideal exit: 29 Jul 2022 (T+270)
14,235 shares@ US$30.140.0010% mcap100.0% of flowCommon StockSEC:0001140361-21-036421:0
Ideal exit: 29 Jul 2022 (T+270)
7,558 sharesCommon StockSEC:0001140361-21-017430
7,558 sharesCommon StockSEC:0001140361-21-017430:0
4 of 4 declarations
About ENGELSEN STEINAR J
Steinar J. Engelsen is a Director at INSMED Inc. In this role, he participates in the governance of the company and strategic decision-making. His experience in the pharmaceutical sector is an asset for INSMED, which focuses on developing treatments for rare diseases.
